Evidence map›Paper›PMID 34564428›Full record

ArticleMetabolites2021

Concentrations of Fecal Bile Acids in Participants with Functional Gut Disorders and Healthy Controls.

Shanalee C James, Karl Fraser, Wayne Young, Phoebe E Heenan, Richard B Gearry, Jacqueline I Keenan, Nicholas J Talley, Susan A Joyce, Warren C McNabb, Nicole C Roy

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Shanalee C JamesThe Riddet Institute, Massey University, Palmerston North 4474, New Zealand.
Karl FraserThe Riddet Institute, Massey University, Palmerston North 4474, New Zealand.ORCID 0000-0002-1136-4024
Wayne YoungThe Riddet Institute, Massey University, Palmerston North 4474, New Zealand.
Phoebe E HeenanHigh-Value Nutrition National Science Challenge, Auckland 1023, New Zealand.
Richard B GearryHigh-Value Nutrition National Science Challenge, Auckland 1023, New Zealand.
Jacqueline I KeenanDepartment of Surgery, University of Otago, Christchurch 8011, New Zealand.
Nicholas J TalleySchool of Medicine and Public Health, The University of Newcastle, Callaghan, Newcastle 2308, Australia.ORCID 0000-0003-2537-3092
Susan A JoyceSchool of Biochemistry and Cell Biology and APC Microbiome Ireland, University of College Cork, T12 K8AF Cork, Ireland.ORCID 0000-0003-4771-3123
Warren C McNabbThe Riddet Institute, Massey University, Palmerston North 4474, New Zealand.
Nicole C RoyThe Riddet Institute, Massey University, Palmerston North 4474, New Zealand.ORCID 0000-0002-6744-9705
AgResearch · NZUniversity of Otago · NZRiddet Institute · NZAPC Microbiome Institute · IEUniversity of Newcastle Australia · AU

Funding

Ministry for Business Innovation and Employment UOAX1902
6 · The paper itself

Abstract

Bile acids are metabolites involved in nutrient absorption and signaling with levels influenced by dietary intake, metabolic processes, and the gut microbiome. We aimed to quantify 23 bile acids in fecal samples to ascertain if concentrations differed between healthy participants and those with functional gut disorders. Fecal bile acids were measured using liquid chromatography-mass spectrometry (LC-MS) in the COMFORT (The Christchurch IBS cohort to investigate mechanisms for gut relief and improved transit) cohort of 250 participants with Rome IV IBS (IBS-constipation (C), IBS-diarrhea (D), IBS-mixed (M)), functional gut disorders (functional constipation (FC), functional diarrhea (FD)) and healthy controls (FC

Indexed as

bile acidsfunctional gut disorderirritable bowel syndromeliquid chromatography-mass spectrometry

Identifiers

PMID34564428
PMCPMC8464974
OpenAlexW3198711639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.